Amalgamated Bank’s Genomic Health, Inc. GHDX Stock Holding History

Amalgamated Bank’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-4,943	Closed	-$335K	–	1856
2019 Q3	$335K	Buy	4,943 +95	+2%	+$6.52K	0.01%	1255
2019 Q2	$282K	Buy	4,848 +1,564	+48%	+$92.7K	0.01%	1385
2019 Q1	$230K	Buy	3,284 +127	+4%	+$9.42K	0.01%	1430
2018 Q4	$203K	Buy	+3,157	New	+$221K	0.01%	1411

Amalgamated Bank's GHDX Position: Q4 2019 in Review

Amalgamated Bank sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 4,943 shares — an estimated $335K sold.

Amalgamated Bank first reported a position in GHDX in Q4 2018 and held it in 4 quarters. The position peaked at $335K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Amalgamated Bank reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Amalgamated Bank sold 4,943 Genomic Health, Inc. shares in Q4 2019, an estimated $335K.
Amalgamated Bank first reported a position in Genomic Health, Inc. in Q4 2018 and held it in 4 quarters.
Amalgamated Bank's Genomic Health, Inc. position peaked at $335K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Amalgamated Bank's 13F filing for Q4 2019, filed 13 Feb 2020.